Sygnature Discovery pumps £3.75M into data management system

08 Nov 2023
www.fiercebiotech.com
Acquisition
Sygnature Discovery pumps £3.75M into data management system
Preview
Source: FierceBiotech
An investment into Azenta Life Sciences is part of Sygnature Discovery’s goal to become a market leader in the drug discovery market for hit-finding capabilities.
Sygnature Discovery,  a U.K.-based preclinical contractor, is pumping 3.75 million pounds sterling ($4.6 million) into Azenta Life Sciences’ compound management storage system that will allow it to store customer libraries.
Azenta’s service, along with high-throughput screening (HTS) capacity, will allow automated management and screening of compounds from various sources at one location, according to a Nov. 2 press release. With it, Sygnature will be able to store more than 2 million compounds under optimal conditions for stability, and compound samples will be tracked automatically from the storage well to the final HTS assay data point.
The investment is part of Sygnature’s goal to become a market leader in the drug discovery market for hit-finding capabilities.
In August, Sygnature bought Canadian CRO NuChem Sciences for an undisclosed price, giving the company integrated and standalone discovery services that span medicinal, synthetic, scale-up, process and computational chemistry as well as drug metabolism and pharmacokinetics, in vitro biology and in vivo pharmacology.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.